A. Gringeri

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

Jan Astermark, Sharyne Donfield, Donna DiMichele et al. · Blood · 2006 · 471 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

A. Gringeri, Björn Lundin, Sylvia von Mackensen et al. · Journal of Thrombosis and Haemostasis · 2011 · 449 citations · Full text

Medicine, Hematology, Pediatrics +7

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

A. Gringeri, LG Mantovani, L Scalone et al. · Blood · 2003 · 369 citations

Pharmacy, Hematology, Pharmacoeconomics +11

Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.

John J. Costa, George D. Demetri, Terence J. Harrist et al. · The Journal of Experimental Medicine · 1996 · 271 citations · Full text

Medicine, Dermatology, Immunology +13

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

Erik Berntorp, Jan Astermark, Sven Björkman et al. · Haemophilia · 2003 · 270 citations · Full text

Medicine, Hematology, Pharmacotherapy +12